New antibody shots aim to stop itchy eyes from birch pollen
NCT ID NCT07309432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting. The goal is to see if the drugs safely relieve itching and redness better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Andover Eye Associates
RECRUITINGAndover, Massachusetts, 01810, United States
-
Somnos Clinical Research
RECRUITINGLincoln, Nebraska, 68510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental antibodies aim to block cat allergy eye itch
- Eye insert could ease allergy symptoms for contact lens wearers
- New eye drops zap allergy itch in just minutes
- Which eye drop stings less? small study pits flarex against lotemax SM
- Scientists hunt for eye disease clues in your tears
- Can ectoin sprays and drops soothe hay fever? new study investigates